Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,040 | 2,770 | 320 | 1,030 | 7,210 |
| Receivables | 60 | 150 | 10 | 130 | 110 |
| Other current assets | 40 | 40 | 30 | 40 | 50 |
| TOTAL | $1,140 | $2,960 | $360 | $1,200 | $7,370 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 1,670 |
| Other Non-Current Assets | 2,250 | 1,600 | 1,600 | 1,592 | 1,560 |
| TOTAL | $2,250 | $1,600 | $1,600 | $1,592 | $3,230 |
| Total Assets | $4,470 | $5,540 | $2,970 | $3,810 | $9,980 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 700 | 240 | 830 | 790 | 130 |
| Accrued Expenses | 80 | 30 | 30 | 20 | 40 |
| TOTAL | $940 | $290 | $890 | $850 | $210 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $10 |
| Total Liabilities | $940 | $290 | $890 | $850 | $220 |
| Shareholders' Equity | |||||
| Common Shares | 150 | 150 | 130 | 130 | 120 |
| Retained earnings | -41,920 | -40,150 | -39,260 | -38,380 | -34,510 |
| Other shareholders' equity | -10 | -10 | -20 | -20 | 5,960 |
| TOTAL | $3,520 | $5,240 | $2,080 | $2,960 | $9,750 |
| Total Liabilities And Equity | $4,460 | $5,530 | $2,970 | $3,810 | $9,970 |